Do you use bone turnover markers to assess medical adherence in patients treated for osteoporosis?

I find the bone remodeling markers very helpful. First and foremost, I want to be sure that if I am going to put a patient on an antiresorptive medication that the patient has evidence for high bone turnover over i.e., increased osteoclastic activity. If the bone remodeling markers for both bone formation (PiNP and or osteocalcin) and bone resorption (urine NTX or serum CTX) are low, then I am more concerned about adynamic bone disease and would therefore consider an anabolic agent like Forteo o...

Yes. Particularly when antiresorptive drugs are used. A bone resorption marker can indicate appropriate use of the drug.